Floatz logo

Levoleucovorin

Chemotherapeutic Toxicity

Sun Yat-sen UniversityPhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

13 Active assets in the Chemotherapeutic Toxicity cohort.

Asset / SponsorPhaseRating
Inno-206
Instituto do Cancer do Estado de São Paulo
Phase 4BB
PREDNISONE TABLETS
Instituto do Cancer do Estado de São Paulo
Phase 4BB
Cyclophosphamide
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 4BB
Daunorubicin
Instituto do Cancer do Estado de São Paulo
Phase 4B
Clostridium Butyricum
The Affiliated Hospital of Qingdao University
Phase 4B

View all 21 →

Same molecule, other indications

Levoleucovorin is also rated in:

gastroesophageal junction adenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
Advanced/Metastatic Gastroesophageal AdenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →